Cellectar, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
10
Ending by 2030
Mar 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 14, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,540,968 | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,535,641 | Phospholipid analogs as diapeutic* agents and methods thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 7,700,075 | Virtual colonoscopy with radiolabeled phospholipid ether analogs In force · From the USPTO record | In force | From the USPTO record | |
| US 7,811,548 | Fluorescent phospholipid ether compounds and compositions In force · From the USPTO record | In force | From the USPTO record | |
| US 8,871,181 | Fluorescent phospholipid ether compounds, compositions, and methods of use In force · From the USPTO record | In force | From the USPTO record | |
| US 7,893,286 | Method for the synthesis of phospholipid ethers In force · From the USPTO record | In force | From the USPTO record | |
| US 8,022,235 | Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use In force · From the USPTO record | In force | From the USPTO record | |
| US 9,616,140 | Fluorescent phospholipid ether compounds, compositions, and methods of use In force · From the USPTO record | In force | From the USPTO record | |
| US 9,339,564 | Ether and Alkyl Phospholipid Compounds for Treating Cancer and Imaging and Detection of Cancer In force · High confidence | In force | High confidence | |
| US 10,004,818 | Ether and Alkyl Phospholipid Compounds for Treating Cancer and Imaging and Detection of Cancer In force · High confidence | In force | High confidence |
Also on record, not counted in the 17: 5 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 4 no status recorded